Comparison between the new Xpert <i>Mycobacterium tuberculosis/</i>Rifampicin (MTB/RIF) Ultra assay and Xpert MTB/RIF for diagnosis of extra-pulmonary tuberculosis in a tertiary care center.

Microbiol Spectr · 2025 · PMC12671184 · PMID 41211977

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Our study illustrates a highly significant difference in sensitivity of more than 45% between Xpert MTB/RIF and Xpert MTB/RIF Ultra, which can be very well explained by the greater ability in view of the lower detection threshold of Xpert MTB/RIF Ultra.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Comparison between the new Xpert &lt;i&gt;Mycobacterium tuberculosis/&lt;/i&gt;Rifampicin (MTB/RIF) Ultra assay and Xpert MTB/RIF for diagnosis of extra-pulmonary tuberculosis in a tertiary care center.

The sentences

Comparison between the new Xpert <i>Mycobacterium tuberculosis/</i>Rifampicin (MTB/RIF) Ultra assay and Xpert MTB/RIF for diagnosis of extra-pulmonary tuberculosis in a tertiary care center.